These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39219549)

  • 1. Allergen immunotherapy effectiveness in specific nasal reactivity of children with local allergic rhinitis.
    Loureiro G; Tavares B; Farinha I; Cunha F; Todo-Bom A
    Eur Ann Allergy Clin Immunol; 2024 Sep; ():. PubMed ID: 39219549
    [No Abstract]   [Full Text] [Related]  

  • 2. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).
    Pfaar O; Bachert C; Bufe A; Buhl R; Ebner C; Eng P; Friedrichs F; Fuchs T; Hamelmann E; Hartwig-Bade D; Hering T; Huttegger I; Jung K; Klimek L; Kopp MV; Merk H; Rabe U; Saloga J; Schmid-Grendelmeier P; Schuster A; Schwerk N; Sitter H; Umpfenbach U; Wedi B; Wöhrl S; Worm M; Kleine-Tebbe J; Kaul S; Schwalfenberg A
    Allergo J Int; 2014; 23(8):282-319. PubMed ID: 26120539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proportion of local allergic rhinitis to Dermatophagoides pteronyssinus in children.
    Buntarickpornpan P; Veskitkul J; Pacharn P; Visitsunthorn N; Vichyanond P; Tantilipikorn P; Jirapongsananuruk O
    Pediatr Allergy Immunol; 2016 Sep; 27(6):574-9. PubMed ID: 27289005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of D. pteronyssinus immunotherapy in local allergic rhinitis: a double-blind placebo-controlled clinical trial.
    Rondón C; Campo P; Salas M; Aranda A; Molina A; González M; Galindo L; Mayorga C; Torres MJ; Blanca M
    Allergy; 2016 Jul; 71(7):1057-61. PubMed ID: 27008542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different Development Forms of Local Allergic Rhinitis towards Birch.
    Bozek A; Winterstein J; Galuszka B; Jarzab J
    Biomed Res Int; 2020; 2020():3408561. PubMed ID: 32596297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of local allergic rhinitis to Dermatophagoides pteronyssinus in chronic rhinitis with negative skin prick test.
    Tantilipikorn P; Siriboonkoom P; Sookrung N; Thianboonsong A; Suwanwech T; Pinkaew B; Asanasaen P
    Asian Pac J Allergy Immunol; 2021 Jun; 39(2):111-116. PubMed ID: 30903999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal cytology can predict clinical efficacy of subcutaneous immunotherapy in intermittent allergic rhinitis.
    Jura-Szołtys E; Gawlik R; Branicka O; Stryjewska-Makuch G; Glück J
    Postepy Dermatol Alergol; 2022 Dec; 39(6):1110-1115. PubMed ID: 36686010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential class switch recombination to IgE and allergen-induced accumulation of IgE
    Testera-Montes A; Palomares F; Jurado-Escobar R; Fernandez-Santamaria R; Ariza A; Verge J; Salas M; Campo P; Mayorga C; Torres MJ; Rondon C; Eguiluz-Gracia I
    Allergy; 2022 Sep; 77(9):2712-2724. PubMed ID: 35340036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific immunotherapy in local allergic rhinitis: A randomized, double-blind placebo-controlled trial with Phleum pratense subcutaneous allergen immunotherapy.
    Rondón C; Blanca-López N; Campo P; Mayorga C; Jurado-Escobar R; Torres MJ; Canto G; Blanca M
    Allergy; 2018 Apr; 73(4):905-915. PubMed ID: 29168570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary Immunoglobulin A, E, and G4 Levels Specific to Dermatophagoides pteronyssinus in Allergic Rhinitis Patients Treated With Subcutaneous Immunotherapy.
    Liu Y; Xing Z; Wang J; Geng C
    Am J Rhinol Allergy; 2018 Nov; 32(6):458-464. PubMed ID: 30124065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Chronic Rhinosinusitis With Nasal Polyps in Endotypes of Dermatophagoides pteronyssinus-Induced Rhinitis.
    De Marchi S; Cecchin E; De Marchi SU; Iuri F; Sechi LA
    J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1506-1514.e2. PubMed ID: 35074602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous allergen immunotherapy for asthma: A randomized, double-blind, placebo-controlled study with a standardized
    Castro-Almarales RL; Ronquillo-Díaz M; Álvarez-Castelló M; Rodríguez-Canosa J; González-León M; Enríquez-Domínguez I; Navarro-Viltre BI; Mateo-Morejón M; Oliva-Díaz Y; Ramírez-González W; Cox L; Labrada-Rosado A
    World Allergy Organ J; 2020 Apr; 13(4):100098. PubMed ID: 32308779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of nasal allergen vs allergen exposure chambers to evaluate allergen immunotherapy.
    Hossenbaccus L; Ellis AK
    Expert Rev Clin Immunol; 2021 May; 17(5):461-470. PubMed ID: 33729907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergen-specific immunotherapy for local allergic rhinitis: a systematic review and meta-analysis.
    Hoang MP; Samuthpongtorn J; Chitsuthipakorn W; Seresirikachorn K; Snidvongs K
    Rhinology; 2022 Feb; 60(1):11-19. PubMed ID: 34609382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal allergen-neutralizing antibodies correlate closely with tolerated intranasal allergen challenge dose following grass pollen subcutaneous immunotherapy in patients with local allergic rhinitis.
    Eguiluz-Gracia I; Parkin RV; Layhadi JA; Palmer E; Meng X; Zhu R; Sahiner U; Durham SR; Torres MJ; Mayorga C; Rondon C; Shamji MH
    Allergy; 2024 Aug; 79(8):2197-2206. PubMed ID: 38483174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of silver birch and house dust mite extracts derived from licensed sublingual tablets for nasal allergen challenge.
    Olivieri B; Gil AJ; Stoenchev K; Durham SR; Scadding G
    Clin Transl Allergy; 2024 May; 14(5):e12360. PubMed ID: 38779783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of
    Huang R; Qin R; Hu Q; Zhu Z; Liu Y; Luo T; Li J
    Allergy Asthma Immunol Res; 2020 Sep; 12(5):844-858. PubMed ID: 32638564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Allergen Immunotherapy Alone and in Conjunction With Turbinate Surgery for Nasal Obstruction in Perennial Allergic Rhinitis Patients.
    Chong AXJ; Alvarado R; Rimmer J; Campbell RG; Kalish L; Png LH; Harvey RJ
    Ann Otol Rhinol Laryngol; 2024 Jun; 133(6):545-553. PubMed ID: 38414187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate and dual response to nasal challenge with Dermatophagoides pteronyssinus in local allergic rhinitis.
    López S; Rondón C; Torres MJ; Campo P; Canto G; Fernandez R; Garcia R; Martínez-Cañavate A; Blanca M
    Clin Exp Allergy; 2010 Jul; 40(7):1007-14. PubMed ID: 20337651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.